Under 5 years . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 80 2.5 5 to 9 years . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 91 2.9 10 to 14 years . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 105 3.3 15 to 19 years . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 105 3.3 20 to 24 years . . . . . . . . . . . . . . . . . . . . . ....

Under 5 years . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 40 6.2 5 to 9 years . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 34 5.3 10 to 14 years . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 45 7.0 15 to 19 years . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 38 5.9 20 to 24 years . . . . . . . . . . . . . . . . . . . . . . ....

This plain language summary serves as an overview in explaining earwax (cerumen). The summary applies to patients older than 6 months with a clinical diagnosis of earwax impaction and is based on the 2017 update of the Clinical Practice Guideline: Earwax (Cerumen Impaction). The evidence-based guideline includes research that supports diagnosis and treatment of earwax impaction. The guideline w...

Under 5 years . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 65 5.2 5 to 9 years . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 87 6.9 10 to 14 years . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 85 6.7 15 to 19 years . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 90 7.1 20 to 24 years . . . . . . . . . . . . . . . . . . . . . . ....

Under 5 years . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 52 5.4 5 to 9 years . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 65 6.7 10 to 14 years . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 71 7.3 15 to 19 years . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 58 6.0 20 to 24 years . . . . . . . . . . . . . . . . . . . . . . ....

AIMS The aim of the present study was to assess the clinical performance of a dual X-ray source multi-slice CT (MSCT) with high temporal resolution to assess the coronary status in patients with an intermediate pretest likelihood for significant coronary artery disease (CAD) without using negative chronotropic pretreatment. METHODS AND RESULTS Dual-source CT (DSCT) angiography (Siemens Defini...

Nucleic acid sequence-based amplification assays for detection of human cytomegalovirus (HCMV) immediate-early and pp67 mRNA in 65 amniotic fluid samples tested for prenatal diagnosis of congenital HCMV infection showed sensitivity, specificity, and negative and positive predictive values >90%.

This paper studies stable and (one-sided) strategy-proof matching rules in manyto-onematchingmarkets with contracts. First, the number of such rules is shown to be at most one. Second, the doctor-optimal stable rule, whenever it exists, is shown to be the unique candidate for a stable and strategy-proof rule. Third, a stable and strategyproof rule, when exists, is shown to be second-best optima...

We propose an adaptive framework for branching rule selection that is based on a set of branching rules. Each branching rule is attached a preference value that is dynamically adapted with respect to conflict analysis. Thus, our approach brings together two essential features of modern SAT algorithms which were traditionally independent from each other. Experimental results show the feasibility...